Shanghai Allist Pharmaceuticals Future Growth
Future criteria checks 3/6
Shanghai Allist Pharmaceuticals is forecast to grow earnings and revenue by 18.4% and 17% per annum respectively. EPS is expected to grow by 18.4% per annum. Return on equity is forecast to be 23.6% in 3 years.
Key information
18.4%
Earnings growth rate
18.4%
EPS growth rate
| Pharmaceuticals earnings growth | 18.8% |
| Revenue growth rate | 17.0% |
| Future return on equity | 23.6% |
| Analyst coverage | Low |
| Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Shanghai Allist Pharmaceuticals Co., Ltd.'s (SHSE:688578) Shares Bounce 43% But Its Business Still Trails The Market
Oct 08
Does Shanghai Allist Pharmaceuticals (SHSE:688578) Deserve A Spot On Your Watchlist?
Sep 23Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 30Should You Be Adding Shanghai Allist Pharmaceuticals (SHSE:688578) To Your Watchlist Today?
Apr 01Optimistic Investors Push Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Shares Up 26% But Growth Is Lacking
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5,120 | 1,916 | 1,808 | 1,813 | 3 |
| 12/31/2025 | 4,214 | 1,599 | 1,627 | 1,550 | 3 |
| 12/31/2024 | 3,424 | 1,318 | 1,060 | 1,111 | 3 |
| 9/30/2024 | 3,204 | 1,297 | 1,219 | 1,449 | N/A |
| 6/30/2024 | 2,846 | 1,092 | 1,163 | 1,219 | N/A |
| 3/31/2024 | 2,485 | 915 | 985 | 1,060 | N/A |
| 12/31/2023 | 2,018 | 644 | 607 | 675 | N/A |
| 9/30/2023 | 1,621 | 487 | 429 | 520 | N/A |
| 6/30/2023 | 1,239 | 312 | 153 | 271 | N/A |
| 3/31/2023 | 956 | 188 | 20 | 122 | N/A |
| 12/31/2022 | 791 | 131 | -52 | 92 | N/A |
| 9/30/2022 | 560 | -63 | -199 | -26 | N/A |
| 6/30/2022 | 709 | 123 | -62 | 149 | N/A |
| 3/31/2022 | 604 | 40 | -173 | 65 | N/A |
| 12/31/2021 | 530 | 18 | -163 | 29 | N/A |
| 9/30/2021 | 488 | 29 | -139 | 38 | N/A |
| 6/30/2021 | 122 | -255 | -344 | -210 | N/A |
| 3/31/2021 | 37 | -289 | -340 | -228 | N/A |
| 12/31/2020 | 1 | -311 | -285 | -197 | N/A |
| 9/30/2020 | 1 | -354 | -414 | -291 | N/A |
| 3/31/2020 | 1 | -299 | N/A | N/A | N/A |
| 12/31/2019 | 1 | -398 | -349 | -259 | N/A |
| 12/31/2018 | 5 | -97 | -133 | -97 | N/A |
| 12/31/2017 | 8 | -39 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688578's forecast earnings growth (18.4% per year) is above the savings rate (2.8%).
Earnings vs Market: 688578's earnings (18.4% per year) are forecast to grow slower than the CN market (26.2% per year).
High Growth Earnings: 688578's earnings are forecast to grow, but not significantly.
Revenue vs Market: 688578's revenue (17% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688578's revenue (17% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688578's Return on Equity is forecast to be high in 3 years time (23.6%)